• 9 Oct 2025

Dr Andy Jones

Andy Jones has over 30 years’ experience in CMC (Chemistry, Manufacturing and Controls) development and pharma manufacturing services. He has been instrumental in leading the development, scale-up, and establishment of manufacturing processes for several blockbuster medicines. He has held many senior leadership positions in AstraZeneca, including Head of Manufacturing: Science and Technology, and Vice President for Pharmaceutical Innovation. He has recently concluded his role as Industrial Strategy Challenge Director in Medicines Manufacturing at Innovate UK, and consequently has a broad understanding of the exciting innovation happening in the global Pharma and Biotech manufacturing market.

Andy’s experience in the CMC landscape will underpin CatSci’s growth through supporting the expansion of our core capabilities and extension of our offerings into new emerging areas of advanced medicines manufacturing.

Resources & Insights

  • 27 May 2026
Celebrating 15 Years of CatSci – From Catalysis to Integrated Drug Development Partner  
  • News
  • 11 May 2026
CatSci Achieves ISO 27001 Certification, Demonstrating its Commitment to Client Data Security
  • News
  • 1 Apr 2026
  • Jean-Baptiste Vendeville
De-Risking Suzuki Development Through Integrated HTE and DoE
  • Analytical Chemistry
  • Chemical Development
  • Design of Experiments
  • High Throughput Experimentation
  • HTE
  • Scale-up
  • Whitepapers
2 MB
  • 23 Mar 2026
HTE-Enabled Suzuki Optimisation for Cost Reduction
  • High Throughput Experimentation
  • HTE
  • Case Studies
244 KB